Synovus Financial Corp lowered its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 85.2% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 1,493 shares of the semiconductor company’s stock after selling 8,629 shares during the period. Synovus Financial Corp’s holdings in Synopsys were worth $737,000 at the end of the most recent quarter.
A number of other institutional investors have also bought and sold shares of SNPS. Brighton Jones LLC grew its position in shares of Synopsys by 5.7% during the fourth quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after purchasing an additional 50 shares in the last quarter. Integrated Wealth Concepts LLC lifted its holdings in Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company’s stock worth $326,000 after purchasing an additional 79 shares in the last quarter. NewEdge Advisors LLC boosted its stake in Synopsys by 15.1% in the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company’s stock worth $1,291,000 after purchasing an additional 395 shares during the period. AlphaQuest LLC boosted its stake in Synopsys by 423.1% in the 2nd quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 55 shares during the period. Finally, Fielder Capital Group LLC purchased a new stake in Synopsys during the 2nd quarter valued at approximately $201,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Synopsys Stock Performance
Synopsys stock opened at $439.94 on Monday. The company’s 50-day moving average price is $474.06 and its 200-day moving average price is $481.90. The company has a quick ratio of 1.52, a current ratio of 1.62 and a debt-to-equity ratio of 0.48. The company has a market cap of $84.27 billion, a PE ratio of 55.06, a price-to-earnings-growth ratio of 3.66 and a beta of 1.12. Synopsys, Inc. has a twelve month low of $365.74 and a twelve month high of $651.73.
Key Headlines Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: NVIDIA added a large stake in Synopsys (reported ~4.8M shares, >$2.2B at end-Q4), highlighting strategic alignment between SNPS and AI/semiconductor leaders and lending a strong institutional vote of confidence. NVIDIA’s 13F Bombshell: A New AI Power Trio Emerges
- Positive Sentiment: Board refresh: Synopsys appointed former Deloitte executive Peter A. Shimer to the board and expanded the board as part of governance updates — adds deep financial and leadership experience that investors often view as supportive for oversight and capital allocation. Synopsys Appoints Former Deloitte Executive Peter Shimer to Board of Directors and Announces Board Transitions
- Positive Sentiment: Partnership expansion: Synopsys deepened its AI design and security capabilities via a SimuTech partnership, which could broaden product adoption in AI-focused chip design workflows. Synopsys Deepens AI Design And Security Reach With SimuTech Partnership
- Neutral Sentiment: Analysts and earnings watch: Multiple previews (Zacks/Yahoo) flag Q1 results as a near-term catalyst — key metrics vs. guidance will likely drive short-term volatility around the report. Synopsys (SNPS) Q1 Earnings on the Horizon: Analysts’ Insights on Key Performance Measures
- Neutral Sentiment: Mixed investor reaction coverage discusses AI-disruption fears, chiplet competition and the Ansys deal — narrative is mixed and could add noise to sentiment without a single clear directional effect. How Investors Are Reacting To Synopsys (SNPS) AI Disruption Fears Amid Chiplet Push And Ansys Deal
- Negative Sentiment: HSBC downgraded SNPS from Buy to Hold and set a $455 price target, a move that can weigh on sentiment and selling pressure even though the PT still implies modest upside. SNPS: HSBC downgrades
Insider Buying and Selling at Synopsys
In related news, CFO Shelagh Glaser sold 3,657 shares of Synopsys stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Janet Lee sold 250 shares of the company’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares in the company, valued at $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,157 shares of company stock valued at $1,945,036 over the last ninety days. 0.62% of the stock is owned by insiders.
Analysts Set New Price Targets
Several research firms have recently issued reports on SNPS. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and reduced their price objective for the company from $525.00 to $500.00 in a research report on Monday, December 8th. Piper Sandler downgraded shares of Synopsys from an “overweight” rating to a “neutral” rating and reduced their price target for the company from $602.00 to $520.00 in a report on Tuesday, January 13th. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a report on Thursday, January 22nd. JPMorgan Chase & Co. lifted their target price on Synopsys from $600.00 to $650.00 and gave the stock an “overweight” rating in a report on Thursday, December 11th. Finally, Citigroup started coverage on Synopsys in a research report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. Nine equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Synopsys currently has a consensus rating of “Hold” and a consensus price target of $547.00.
Read Our Latest Analysis on SNPS
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
